NL-OMON40114已完成不适用
The effect of natalizumab treatment on functional adaptation in multiple sclerosis (MS) - Natalizumab and functional adaptation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Meet safety criteria for MRI
- •Group 1: starting or recently started natalizumab
- •Group 2: using standard treatment
排除标准
- •MS other than RRMS
- •Presence or history of psychiatric disease
- •Presence or history of neurologic disease
- •Presence or history of alcohol or drug abuse
研究者
相似试验
尚未招募
不适用
se of Natalizumab in patients with Multiple SclerosisQuality of lifeRBR-6jhtvfyFaculdade de Ciências Farmacêuticas, Alimentos e Nutrição da Universidade Federal de Mato Grosso do Sul
已完成
不适用
Retrospective chart review on natalizumab: Efficacy and safety of long-term treatment with natalizumab in Japanese patients with RRMSRelapsing-Remitting Multiple SclerosisJPRN-UMIN000033924IRINO MEDICAL CLINIC, LLC85
已完成
2 期
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)Relapsing-Remitting Multiple SclerosisNCT01405820Biogen290
尚未招募
2 期
The effect of Adalimumab in the treatment of patients with chronic schizophreniaSchizophrenia.SchizophreniaIRCT20090117001556N126Tehran University of Medical Sciences50
已完成
不适用
Clinical effects of treatment with omalizumab in patients with asthmaBronchial asthmaJPRN-UMIN000002765Atami Hospital International University of Health and Welfare40